» Authors » Jose C Arevalo-Lorido

Jose C Arevalo-Lorido

Explore the profile of Jose C Arevalo-Lorido including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 6
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mota-Zamorano S, Gonzalez L, Robles N, Valdivielso J, Arevalo-Lorido J, Lopez-Gomez J, et al.
Ann Med . 2022 Oct; 54(1):3039-3051. PMID: 36314849
Background: Diabetic nephropathy (DN) has become the major cause of end-stage kidney disease and is associated to an extremely high cardiovascular (CV) risk. Methods: We screened 318 DN patients for...
2.
Gonzalez L, Robles N, Mota-Zamorano S, Arevalo-Lorido J, Valdivielso J, Lopez-Gomez J, et al.
Front Pharmacol . 2022 May; 13:817020. PMID: 35586043
Nephrosclerosis patients have a high cardiovascular (CV) risk that is very often of more concern than the renal disease itself. We aimed to determine whether variants in phospholipase-related genes, associated...
3.
Carretero Gomez J, Ena J, Segui Ripoll J, Carrasco-Sanchez F, Gomez Huelgas R, Mateos Polo L, et al.
Int J Clin Pract . 2020 Jun; 74(10):e13586. PMID: 32533906
Aims: We aimed to determine the efficacy and safety of sodium-glucose cotransporter type 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists to prevent worsening urinary albumin-to-creatinine ratio as an early...
4.
Arevalo-Lorido J, Carretero-Gomez J, Robles N
Int J Neurosci . 2020 Apr; 131(6):609-614. PMID: 32228334
Background: The role of serum uric acid (SUA) after stroke is controversial and can be influenced by renal disease. Aim: to analyse the role of SUA in the acute phase...